Table 6 Summary of the main significant results
PS vs. C | R vs. PS | RTC vs. R | RTCC vs. RTC | |
|---|---|---|---|---|
PL PUFA | ||||
ω6 PUFAs | ↓ 18:2 and ↑ 20:4, C22:4, C22:5; | ↑ 18:2, ↓ 20:4, 22:4 and 22:5; | - | - |
ω3 PUFAs | ↓ | ↑ 18:3, 22:5 and 22:6 | - | - |
PUFAs/SFAs | ↓ | ↑ | - | - |
Ag2 pathway | ||||
mRNA Ag2R-1b | - | - | ↑ | ↓ |
Collagen | - | - | ↑ | ↓ |
Metabolism | ||||
mRNA for PDK4 | - | - | ↑ | ↓ |
DG | ↓ | ↑ | - | - |
TG | - | - | - | ↓ |
Oxidative stress | ||||
Thiol group | - | ↑ | - | - |
TBARS | ↓ | - | - | - |
FRAP | ↓ | - | - | - |
SOD activity | ↓ | - | - | - |
GPX activity | - | - | ↑ | - |
mRNA for SOD2 | - | - | ↑ | ↓ |
mRNA for GPX4 | - | - | ↑ | - |
Apoptosis | ||||
Cleaved caspase-3 | ↓ | - | - | - |
p53 mRNA | - | - | ↓ | - |